CorrlensCorrlens
Correlate

Correlation Analysis

Merck & Co., Inc. vs Oracle Corp

MRK vs ORCL

+0.018

Near-zero positive

When one moves up, the other tends to follow.

MRK logo

Merck & Co., Inc.

MRK

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Market cap 298.8B

ORCL logo

Oracle Corp

ORCL

Oracle provides enterprise applications and infrastructure offerings through a variety of flexible IT deployment models, including on-premises, cloud-based, and hybrid. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system, which is commonly used by the world's largest companies for high-volume online transaction processing workloads. Besides databases, Oracle also sells enterprise resource planning platforms and cloud infrastructure that play an increasingly important role in large language model training and inferencing.

Market cap 418.6B

Apr 9, 2021 — Apr 7, 2026Daily1,254 data pointsStockStockHealthcareTechnology

Time Series

Relative Performance

Green: MRKGray: ORCL36 of 1,254 points (sampled)

Who Moves First

in sync

MRK and ORCL tend to move at the same time.

After testing 13 timing shifts, the strongest relationship was +0.018 (they moved in the same direction).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

-0.255

12 periods · Return correlation when both series rose

Both Falling

-0.135

6 periods · Return correlation when both series fell

Diverging

-0.691

17 periods · Return correlation when series moved apart

R-Squared

0.0%

Share of variance in one series explained by the other.

Trend Agreement

53.9%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

n.s.

95% CI: [-0.037, 0.073]

Scatter

XY Regression

69.1708090100110120130132.451.1100150200250300348.9Merck & Co., Inc.Oracle CorpData pointsFit (r = 0.018)

Pipeline

Data quality details

Pipeline Summary

1,254 paired data points survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

MRK logo

Merck & Co., Inc.

MRK

Market cap 298.8B

Stock · 1,254 raw → 1,254 prepared

Series B

ORCL logo

Oracle Corp

ORCL

Market cap 418.6B

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

12

Estimated crossover points between normalized spreads.

Slope

0.0579

Linear regression slope.

Intercept

120.7259

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 5 hours ago · ID: stock-mrk-vs-stock-orcl-daily